Brind.

Galderma Executive Appointed to Lead Commercial Strategy at Absci Corporation

1 report, 1 independent Updated 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Gerry Muhle was appointed Chief Commercial Officer at Absci Corporation. Muhle joins the company after serving as Senior Vice President and Head of Global Product Strategy at Galderma. His background includes commercial leadership experience at GSK and Allergan, focusing on prescription medicines and consumer skincare.

From manilatimes.net

Why it matters

Some supportBrind's analysis of the reports

Muhle will lead Absci’s commercial strategy, which aims to use direct-to-consumer engagement for its pipeline, including ABS-201. His experience from Galderma and GSK provides insight into commercializing prescription medicines and building consumer-driven brands in the pharmaceutical sector.

From manilatimes.net

Who's involved

  • GaldermaFormer employer of Gerry Muhle, from whom he transitioned to Absci Corporation.
  • GSKCompany where Gerry Muhle previously held commercial leadership experience.

Keep exploring

The entities involved

  • GSK

    British multinational pharmaceutical and biotechnology company

    Nothing else this week.

  • Galderma

    company

    Nothing else this week.

Related events

Coverage

Newest first; wire copies grouped